{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:43:06Z","timestamp":1791218586782,"version":"4.1.0"},"reference-count":215,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jconrel.2012.05.042","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T17:32:53Z","timestamp":1338571973000},"page":"156-169","source":"Crossref","is-referenced-by-count":256,"title":["Challenges in design of translational nanocarriers"],"prefix":"10.1016","volume":"164","author":[{"given":"Qihang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Radosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2012.05.042_bb0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1557\/mrs2009.118","article-title":"Nanopolymeric therapeutics","volume":"34","author":"Tong","year":"2009","journal-title":"MRS Bull."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX (TM)\/Doxil (R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0020","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1200\/JCO.2004.08.048","article-title":"Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia Group B Trial 9342","volume":"22","author":"Winer","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0025","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0030","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0928-0987(00)00166-4","article-title":"Drug targeting","volume":"11","author":"Torchilin","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0040","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2010.05.011","article-title":"Issues in long-term protein delivery using biodegradable microparticles","volume":"146","author":"Ye","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0050","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jps.21124","article-title":"Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic)acid microparticle drug delivery systems","volume":"97","author":"Allison","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jps.21082","article-title":"Engineering biodegradable polyester particles with specific drug targeting and drug release properties","volume":"97","author":"Mohamed","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14227\/DT150208P7","article-title":"Comparison of dialysis and dispersion methods for in vitro release determination of drugs from multimellar liposomes","volume":"15","author":"Shazly","year":"2008","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-3659(96)01611-2","article-title":"Zero-order release of micro- and macromolecules from polymeric devices: the role of the burst effect","volume":"47","author":"Narasimhan","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0075","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.progpolymsci.2010.06.003","article-title":"Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers","volume":"35","author":"Tyrrell","year":"2010","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0080","first-page":"147","article-title":"Micellar solubilization of drugs","volume":"8","author":"Rangel-Yagui","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0085","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/aic.11600","article-title":"Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery","volume":"54","author":"Shen","year":"2008","journal-title":"AlChE J."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0090","doi-asserted-by":"crossref","first-page":"11951","DOI":"10.1021\/jp202335r","article-title":"Near-critical fluid micellization for high and efficient drug loading: encapsulation of paclitaxel into PEG-b-PCL micelles","volume":"115","author":"Tyrrell","year":"2011","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/bc00016a007","article-title":"Preparation of micelle-forming polymer drug conjugates","volume":"3","author":"Yokoyama","year":"1992","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/marc.1987.030080903","article-title":"Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block Copolymer - a new type of polymeric anticancer agent","volume":"8","author":"Yokoyama","year":"1987","journal-title":"Makromol. Chem., Rapid Commun."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1349-7006.2010.01745.x","article-title":"Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300","volume":"102","author":"Harada","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0110","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s11095-010-0120-z","article-title":"PEG-poly(amino acid) block copolymer micelles for tunable drug release","volume":"27","author":"Ponta","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0115","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s11095-010-0234-3","article-title":"Mixed pH-sensitive polymeric micelles for combination drug delivery","volume":"27","author":"Bae","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0120","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/bm1005992","article-title":"Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab ')(2) for hepatocellular carcinoma","volume":"11","author":"Jin","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/mabi.200900335","article-title":"Micellar nanocarriers assembled from doxorubicin-conjugated amphiphilic macromolecules (DOX-AM)","volume":"10","author":"del Rosario","year":"2010","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/nn9014032","article-title":"Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery","volume":"4","author":"Aryal","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/bc900356g","article-title":"Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates","volume":"21","author":"Tong","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0140","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1021\/ja8084675","article-title":"Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles","volume":"131","author":"Tong","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-409X(02)00015-7","article-title":"Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery","volume":"54","author":"Lavasanifar","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/marc.201000708","article-title":"Dual stimuli-responsive polymeric micelles exhibiting \"AND\" logic gate for controlled release of adriamycin","volume":"32","author":"Wei","year":"2011","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1039\/C0PY00256A","article-title":"Doxorubicin conjugated, crosslinked, PEGylated particles prepared via one-pot thiol-ene modification of a homopolymer scaffold: synthesis and in vitro evaluation","volume":"2","author":"Wong","year":"2011","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0160","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1021\/ja909475m","article-title":"Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery","volume":"132","author":"Shen","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2217\/nnm.10.67","article-title":"Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects","volume":"5","author":"Shen","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-3659(02)00088-3","article-title":"Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages","volume":"82","author":"Yoo","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0175","doi-asserted-by":"crossref","first-page":"16892","DOI":"10.1021\/ja053919x","article-title":"Shell click-crosslinked (SCC) nanoparticles: a new methodology for synthesis and orthogonal functionalization","volume":"127","author":"Joralemon","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0180","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1021\/ma0604035","article-title":"Synthesis of reversible shell cross-linked micelles for controlled release of bioactive agents","volume":"39","author":"Li","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2011.04.028","article-title":"Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery","volume":"155","author":"Xiong","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0190","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1021\/ma9815962","article-title":"Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers","volume":"32","author":"Iijima","year":"1999","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/(SICI)1099-1581(199911)10:11<647::AID-PAT918>3.0.CO;2-Y","article-title":"Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol","volume":"10","author":"Kim","year":"1999","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/pola.22430","article-title":"Facile preparation of core-crosslinked micelles from azide-containing thermoresponsive double hydrophilic diblock copolymer via click chemistry","volume":"46","author":"Jiang","year":"2008","journal-title":"J. Polym. Sci. A. Polym. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0205","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1039\/c0jm04410e","article-title":"Folate-conjugated crosslinked biodegradable micelles for receptor-mediated delivery of paclitaxel","volume":"21","author":"Xiong","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0210","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/ma102548m","article-title":"Application of click chemistry in the preparation of poly(ethylene oxide)-block-poly(epsilon-caprolactone) with hydrolyzable cross-links in the micellar core","volume":"44","author":"Garg","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0215","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.biomaterials.2009.01.026","article-title":"Reduction-sensitive polymers and bioconjugates for biomedical applications","volume":"30","author":"Meng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0220","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mabi.201100083","article-title":"Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system","volume":"11","author":"Abdullah Al","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.bioeng.8.061505.095838","article-title":"Polymersomes","volume":"8","author":"Discher","year":"2006","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425240903380446","article-title":"Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction","volume":"7","author":"Kim","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0235","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1021\/ma951301+","article-title":"Mechanisms of the exchange of diblock copolymers between micelles at dynamic equilibrium","volume":"29","author":"Haliloglu","year":"1996","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0240","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.progpolymsci.2007.05.009","article-title":"Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery","volume":"32","author":"Rapoport","year":"2007","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0245","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/B:PHAM.0000033005.25698.9c","article-title":"Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope","volume":"21","author":"Jette","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0250","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2006.11.010","article-title":"In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration","volume":"65","author":"Liu","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-5173(95)04386-1","article-title":"Development of amphiphilic diblock copolymers as micellar carriers of taxol","volume":"132","author":"Zhang","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0927-7765(99)00067-3","article-title":"Development of copolymers of poly(D, L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel","volume":"16","author":"Burt","year":"1999","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0265","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/la0531998","article-title":"Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach","volume":"22","author":"Savic","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0270","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1021\/la703570m","article-title":"Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging","volume":"24","author":"Chen","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0275","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1021\/ma00076a066","article-title":"Dynamic and eletrophoretic light-scattering of a water-soluble comlex formed between pepsin and poly(ethylene glycol)","volume":"26","author":"Xia","year":"1993","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/bm010168s","article-title":"Enzymatic degradation of block copolymers prepared from epsilon-caprolactone and poly(ethylene glycol)","volume":"3","author":"Li","year":"2002","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0285","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.biomaterials.2006.04.039","article-title":"Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers","volume":"27","author":"Chen","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0290","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jps.21092","article-title":"A mechanistic study on the chemical and enzymatic degradation of PEG-Oligo(epsilon-caprolactone) micelles","volume":"97","author":"Carstens","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0295","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.06.015","article-title":"Stability issues of polymeric micelles","volume":"131","author":"Bae","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0300","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1073\/pnas.0707046105","article-title":"Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0305","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0168-3659(99)00167-4","article-title":"Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)\/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - I. Preparation and characterization","volume":"62","author":"Ha","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0310","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0168-3659(99)00207-2","article-title":"Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)\/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - II. Thermo-responsive drug release behaviors","volume":"65","author":"Kim","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0315","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/mp100069p","article-title":"Enhanced stability of PEG-block-poly(N-hexyl stearate L-aspartamide) micelles in the presence of serum proteins","volume":"7","author":"Diezi","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0320","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1021\/bc034113u","article-title":"Core-cross-linked polymeric micelles as paclitaxel carriers","volume":"15","author":"Shuai","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0325","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1016\/j.biomaterials.2007.08.047","article-title":"Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies","volume":"28","author":"Rijcken","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0330","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bm049874u","article-title":"Enhanced stability of core-surface cross-linked micelles fabricated from amphiphilic brush copolymers","volume":"5","author":"Xu","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0335","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/ma102804h","article-title":"Reversible imine shell cross-linked micelles from aqueous RAFT-synthesized thermoresponsive triblock copolymers as potential nanocarriers for \"pH-triggered\" drug release","volume":"44","author":"Xu","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0340","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/ma062493j","article-title":"Polymer micelles stabilization on demand through reversible photo-cross-linking","volume":"40","author":"Jiang","year":"2007","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejpb.2008.09.026","article-title":"Multifunctional and stimuli-sensitive pharmaceutical nanocarriers","volume":"71","author":"Torchilin","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0065-2571(98)00018-1","article-title":"Causes and consequences of acidic pH in tumors: a magnetic resonance study","volume":"39","author":"Stubbs","year":"1999","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0355","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/ja0379666","article-title":"Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression","volume":"126","author":"Miyata","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0360","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/mabi.201000510","article-title":"Disulfide core cross-linked PEGylated polypeptide nanogel prepared by a one-step ring opening copolymerization of N-Carboxyanhydrides for drug delivery","volume":"11","author":"Xing","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0365","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/marc.200900863","article-title":"Core-shell-corona micelle stabilized by reversible cross-linkage for intracellular drug delivery","volume":"31","author":"Wang","year":"2010","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","article-title":"Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities","volume":"55","author":"Saito","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0375","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1021\/ma0613786","article-title":"Novel self-associating poly(ethylene oxide)-block-poly(epsilon-caprolactone) block copolymers with functional side groups on the polyester block for drug delivery","volume":"39","author":"Mahmud","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0380","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0927-7765(99)00058-2","article-title":"Nano-engineering block copolymer aggregates for drug delivery","volume":"16","author":"Allen","year":"1999","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"47","author":"Kataoka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0390","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1021\/ma960120k","article-title":"Soluble stoichiometric complexes from poly(N-ethyl-4-vinylpyridinium) cations and poly(ethylene oxide)-block-polymethacrylate anions","volume":"29","author":"Kabanov","year":"1996","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0395","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1016\/j.biomaterials.2010.07.018","article-title":"Hydrogen bonding-enhanced micelle assemblies for drug delivery","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0400","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1021\/bm200155t","article-title":"Supramolecular copolymer micelles based on the complementary multiple hydrogen bonds of nucleobases for drug delivery","volume":"12","author":"Wang","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0405","first-page":"55","article-title":"Polymer conjugates with anticancer activity","volume":"122","author":"Putnam","year":"1995","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0410","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-3659(01)00330-3","article-title":"Water soluble polymers in tumor targeted delivery","volume":"74","author":"Kopecek","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jconrel.2007.08.016","article-title":"Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells","volume":"124","author":"Malugin","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0420","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-3659(00)00280-7","article-title":"In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates","volume":"68","author":"Yoo","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0425","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-3659(97)00115-6","article-title":"Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor","volume":"50","author":"Yokoyama","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0430","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2010.01.015","article-title":"Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery","volume":"389","author":"Shahin","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0435","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0440","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0445","first-page":"955","article-title":"Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer","volume":"12","author":"Wang","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0450","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0455","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1200\/JCO.2005.02.120","article-title":"Tumoral drug metabolism: overview and its implications for cancer therapy","volume":"23","author":"Michael","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0460","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0465","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.96.1.1","article-title":"Endocytosis and the recycling of plasma-membrane","volume":"96","author":"Steinman","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0475","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2007.12.017","article-title":"A review of stimuli-responsive nanocarriers for drug and gene delivery","volume":"126","author":"Ganta","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0480","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-3659(02)00352-8","article-title":"Cytoplasmic delivery and nuclear targeting of synthetic macromolecules","volume":"87","author":"Jensen","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0485","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.bioeng.8.061505.095735","article-title":"Recent approaches to intracellular delivery of drugs and DNA and organelle targeting","volume":"8","author":"Torchilin","year":"2006","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0490","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/mp100121g","article-title":"Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-Hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond","volume":"7","author":"Rihova","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2003.02.001","article-title":"Polymeric anticancer drugs with pH-controlled activation","volume":"277","author":"Ulbrich","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0500","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-3659(02)00348-6","article-title":"HPMA copolymers with pH-controlled release of doxorubicin \u2014 in vitro cytotoxicity and in vivo antitumor activity","volume":"87","author":"Ulbrich","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0505","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2011.06.015","article-title":"Biodegradable star HPMA polymer-drug conjugates: biodegradability, distribution and anti-tumor efficacy","volume":"154","author":"Etrych","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0510","doi-asserted-by":"crossref","first-page":"17560","DOI":"10.1021\/ja207150n","article-title":"Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery","volume":"133","author":"Du","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0515","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/bc800238f","article-title":"Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates","volume":"20","author":"Shiose","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0520","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0168-3659(92)90181-P","article-title":"Polymers containing enzymatically degradable bonds.12. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly N-(2-hydroxypropyl)-methacrylamide copolymer drug carriers in vitro and antitumor-activity measured in vivo","volume":"18","author":"Subr","year":"1992","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0525","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcis.2011.08.028","article-title":"Self-assembly of pH-sensitive mixed micelles based on linear and star copolymers for drug delivery","volume":"364","author":"Huang","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","article-title":"Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor","volume":"103","author":"Lee","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0535","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/bm200804j","article-title":"pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery","volume":"12","author":"Chen","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0540","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/bm050902y","article-title":"Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles","volume":"7","author":"Xu","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0545","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.colsurfb.2006.01.004","article-title":"Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy","volume":"48","author":"Xu","year":"2006","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0550","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2004.10.004","article-title":"Nuclear delivery of macromolecules: barriers and carriers","volume":"57","author":"Belting","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0555","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0168-3659(01)00504-1","article-title":"pH-sensitive polymers that enhance intracellular drug delivery in vivo","volume":"78","author":"Kyriakides","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0560","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/bj20021945","article-title":"Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles","volume":"372","author":"Jones","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0565","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0570","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.biomaterials.2008.01.031","article-title":"An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection","volume":"29","author":"Lo","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0575","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/17425240903512931","article-title":"Endosomal disruptors in non-viral gene delivery","volume":"7","author":"Minchin","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0580","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nantod.2011.08.002","article-title":"Emerging nanomaterials for targeting subcellular organelles","volume":"6","author":"Huang","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0585","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.addr.2004.10.006","article-title":"Intracellular targeting of polymer-bound drugs for cancer chemotherapy","volume":"57","author":"Nori","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0590","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1078192","article-title":"Micellar nanocontainers distribute to defined cytoplasmic organelles","volume":"300","author":"Savic","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0595","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/mp1000229","article-title":"Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein","volume":"7","author":"Wang","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0600","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2009.06.008","article-title":"A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo","volume":"139","author":"Hatakeyama","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0605","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/bi035802w","article-title":"Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system","volume":"43","author":"Kakudo","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0610","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0169-409X(99)00033-2","article-title":"Application of membrane-active peptides for nonviral gene delivery","volume":"38","author":"Wagner","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0615","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1002\/anie.200605254","article-title":"Targeted charge-reversal nanoparticles for nuclear drug delivery","volume":"46","author":"Xu","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0620","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(01)00221-6","article-title":"Histidine-rich peptides and polymers for nucleic acids delivery","volume":"53","author":"Pichon","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0625","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2217\/nnm.10.86","article-title":"Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery","volume":"5","author":"Shen","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0630","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0635","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/bc800239b","article-title":"Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate","volume":"20","author":"Boomer","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0640","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1021\/ja800336v","article-title":"PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors","volume":"130","author":"Takae","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0645","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/bm050953v","article-title":"In vitro investigation on poly(lactide)-tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy","volume":"7","author":"Zhang","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0650","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0009-8981(98)00089-8","article-title":"Glutathione measurement in human plasma evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC","volume":"275","author":"Jones","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0655","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.biomaterials.2008.12.054","article-title":"Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery","volume":"30","author":"Kurtoglu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0660","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1021\/la904437u","article-title":"Redox-sensitive disassembly of amphiphilic copolymer based micelles","volume":"26","author":"Ryu","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0665","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2011.01.030","article-title":"Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery","volume":"152","author":"Cheng","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0670","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/nl102180s","article-title":"Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging","volume":"10","author":"Sauer","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0675","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1002\/adma.201001417","article-title":"Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers","volume":"22","author":"Kim","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0680","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1039\/c0cc04983b","article-title":"Rapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug delivery","volume":"47","author":"Wen","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0685","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.biomaterials.2009.07.051","article-title":"Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin","volume":"30","author":"Sun","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0690","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2217\/nnm.10.113","article-title":"The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting","volume":"5","author":"Huynh","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0695","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0700","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0705","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0710","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0715","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0005-2736(94)90038-8","article-title":"Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes","volume":"1190","author":"Litzinger","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0720","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0725","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.addr.2009.10.007","article-title":"Structural and chemical aspects of HPMA copolymers as drug carriers","volume":"62","author":"Ulbrich","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0730","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.addr.2009.11.029","article-title":"Micelles based on HPMA copolymers","volume":"62","author":"Talelli","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0735","doi-asserted-by":"crossref","first-page":"536","DOI":"10.18433\/J3JC7C","article-title":"Chitosan mediated targeted drug delivery system: a review","volume":"13","author":"Patel","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0740","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2010.01.017","article-title":"The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting","volume":"143","author":"Chung","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0745","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0750","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.01.025","article-title":"To PEGylate or not to PEGylate, that is not the question","volume":"142","author":"Park","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0755","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1073\/pnas.1011379108","article-title":"Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo","volume":"108","author":"Dhar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0760","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1021\/ja809086q","article-title":"PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation","volume":"131","author":"Prencipe","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0765","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0014-5793(87)80506-9","article-title":"Large unilamellar liposomes with low uptake into the reticuloendothelial system","volume":"223","author":"Allen","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0770","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0005-2736(90)90440-Y","article-title":"Liposomes for the sustained drug release in vivo","volume":"1029","author":"Blume","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0775","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0780","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2004.09.046","article-title":"Role of pegylated liposomal doxorubicin in ovarian cancer","volume":"96","author":"Thigpen","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0785","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0790","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0168-3659(03)00201-3","article-title":"Polymer vesicles in vivo: correlations with PEG molecular weight","volume":"90","author":"Photos","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0795","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1073\/pnas.0707654105","article-title":"Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy","volume":"105","author":"Liu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0800","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0805","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0810","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0815","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2009.10.017","article-title":"CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes","volume":"142","author":"Tagami","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0820","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0825","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0830","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1021\/mp900022m","article-title":"Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage","volume":"6","author":"Christian","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0835","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0840","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2010.07.116","article-title":"Polymer particle shape independently influences binding and internalization by macrophages","volume":"147","author":"Sharma","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0845","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1073\/pnas.1010013108","article-title":"Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles","volume":"108","author":"Merkel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0850","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1021\/ar900035f","article-title":"Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture","volume":"42","author":"Fox","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0855","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/mp900090z","article-title":"Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery","volume":"6","author":"Gullotti","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0860","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1163\/156856208X386246","article-title":"Surface-engineered dendrimers: a solution for toxicity Issues","volume":"20","author":"Mishra","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0865","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(00)00283-2","article-title":"Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo (vol 65, pg 133, 2000)","volume":"68","author":"Malik","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0870","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(03)00232-3","article-title":"Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids","volume":"91","author":"Shin","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0875","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.gt.3302843","article-title":"Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid","volume":"14","author":"Hatakeyama","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0880","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.biomaterials.2011.02.045","article-title":"Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid","volume":"32","author":"Hatakeyama","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0885","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.yexcr.2005.11.022","article-title":"Making the cut: protease-mediated regulation of angiogenesis","volume":"312","author":"Roy","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0890","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1002\/adfm.200900825","article-title":"Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery","volume":"19","author":"Zhou","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0895","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2006.12.008","article-title":"TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors","volume":"118","author":"Sethuraman","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0900","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2008.04.024","article-title":"Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance","volume":"129","author":"Lee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0905","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/17425247.2010.501792","article-title":"Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting","volume":"7","author":"Zaki","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0910","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nbt1204","article-title":"Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins","volume":"24","author":"Rai","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0915","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nnano.2008.46","article-title":"Beyond drug delivery","volume":"3","author":"Ferrari","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0920","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nantod.2010.03.003","article-title":"Targeted nanodelivery of drugs and diagnostics","volume":"5","author":"Phillips","year":"2010","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0925","doi-asserted-by":"crossref","first-page":"H84","DOI":"10.1002\/adma.201003944","article-title":"RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells","volume":"23","author":"Zhu","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0930","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.biomaterials.2010.03.075","article-title":"Virus-mimetic polymeric micelles for targeted siRNA delivery","volume":"31","author":"Xiong","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0935","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2009.12.020","article-title":"Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect","volume":"143","author":"Zhan","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0940","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/CJI.0b013e318234ecf5","article-title":"Targeted drug delivery using immunoconjugates: principles and applications","volume":"34","author":"Pasquetto","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0945","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/CCO.0b013e32834b895c","article-title":"Trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: a review","volume":"23","author":"Mathew","year":"2011","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0950","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2011.03.017","article-title":"Antibody-DM1 conjugates as cancer therapeutics","volume":"307","author":"Lopus","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0955","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.tibtech.2011.06.009","article-title":"Molecular aptamers for drug delivery","volume":"29","author":"Tan","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0960","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1039\/C0NR00646G","article-title":"Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications","volume":"3","author":"Chen","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0965","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10439-011-0280-y","article-title":"Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer","volume":"39","author":"Yoon","year":"2011","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0970","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(97)00084-7","article-title":"Receptor-mediated targeted drug or toxin delivery","volume":"29","author":"Rihova","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1061186X.2011.611518","article-title":"Recent advances in ligand targeted therapy","volume":"20","author":"Trapani","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0980","doi-asserted-by":"crossref","first-page":"14795","DOI":"10.1021\/ja9037406","article-title":"Facile synthesis of polyester dendrimers from sequential click coupling of asymmetrical monomers","volume":"131","author":"Ma","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0985","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1002\/chem.201003495","article-title":"Degradable dual pH- and temperature-responsive photoluminescent dendrimers","volume":"17","author":"Shen","year":"2011","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jconrel.2012.05.042_bb0990","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1021\/nn201371a","article-title":"The role of nanomaterials in translational medicine","volume":"5","author":"Lavik","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2012.05.042_bb0995","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2010.04.008","article-title":"Translational considerations for cancer nanomedicine","volume":"146","author":"Stern","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1000","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7290.2010.00031","article-title":"Nanoparticles for biomedical imaging: fundamentals of clinical translation","volume":"9","author":"Choi","year":"2010","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<68::AID-AJH12>3.0.CO;2-5","article-title":"Bone marrow failure and myelofibrosis in a case of PVP storage disease","volume":"57","author":"Dunn","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/00000478-199711000-00011","article-title":"Cutaneous involvement in polyvinylpyrrolidone storage disease: a clinicopathologic study of five patients, including two patients with severe anemia","volume":"21","author":"Kuo","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1097-0029(19970215)36:4<253::AID-JEMT4>3.0.CO;2-N","article-title":"A review of drug-induced lysosomal disorders of the liver in man and laboratory animals","volume":"36","author":"Schneider","year":"1997","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1020","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jbm.820211106","article-title":"Effect of molecular-weight of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats","volume":"21","author":"Seymour","year":"1987","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1025","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/ie900216r","article-title":"Encapsulation using hyperbranched polymers: from research and technologies to emerging applications","volume":"49","author":"Irfan","year":"2010","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2004.07.003","article-title":"Hydrotropic polymer micelle system for delivery of paclitaxel","volume":"101","author":"Huh","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002800050591","article-title":"Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors","volume":"39","author":"Vail","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1040","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0142-9612(00)00292-1","article-title":"Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers","volume":"22","author":"Kim","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/LPR-120004790","article-title":"Role of complement activation in hypersensitivity reactions to doxil and HYNICPEG liposomes: experimental and clinical studies","volume":"12","author":"Szebeni","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1055","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.biomaterials.2007.11.029","article-title":"Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel","volume":"29","author":"Zhang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1060","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1016\/j.biomaterials.2011.04.075","article-title":"The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00280-005-0091-7","article-title":"Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice","volume":"57","author":"Schluep","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.05.042_bb1070","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1016\/j.biomaterials.2011.09.016","article-title":"Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery","volume":"32","author":"Hu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.042_bb1075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejpb.2011.01.008","article-title":"Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors","volume":"79","author":"Ding","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T05:30:13Z","timestamp":1561786213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912004555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":215,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0168365912004555"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.042","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}